US stock · figures in US dollars · scored on full-year results
Baxter International Baxter International Inc. Common Stock
Baxter International scores 35/100 on fundamentals: in the bottom 7% of 503 scored S&P 500 stocks. Its strongest area is Risk (58/100); its weakest is Business Strength (10/100). It carries 2 warning flags: Weak Spot, Recent Loss.
- Carries a Weak Spot flag
- Carries a Recent Loss flag
A financially stretched, expensively priced stock, but business strength needs attention.
Nearby peers
Ranks #55 of 60 in Healthcare by score
One-Minute Summary
Why Baxter International scores 35
A financially stretched, expensively priced stock, but business strength needs attention.
Business StrengthLowest pillar
10Why 10?
Show 3 charts
Net Profit & Equity, with ROE
Revenue & Net Profit, with Net Margin
Sales grew about 12.1% over 4 years: customers keep spending more with this company.
The company lost money in recent years: the bars below zero are losses, not profits.
Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)
Sales grew about 9.7% over the last 8 quarters: customers keep spending more with this company.
The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.
Financial Safety
33Why 33?
Show 2 charts
Debt vs Equity, with D/E ratio
Borrowings fell about 31.5% over 4 years: the company is steadily getting safer.
Short-term assets vs bills, with Current Ratio
Cash & Dividends
50Why 50?
Show 3 charts
Operating vs Free Cash Flow
Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.
Cash vs Total Debt
Dividends per Share, with Yield
Dividends were cut during this period: payouts here are not guaranteed pocket money.
Price Fairness
17Why 17?
Show chart
Share Price: Weekly Closes (not part of the score)
The share price is up about 24.8% over the past year.
Risk
58Why 58?
Show chart
Revenue vs Inventory, with Inventory % of Revenue
Sector peers
Baxter International (BAX) scores 35/100 (Weak) on Score Your Stock's educational fundamentals model: in the bottom 7% of 503 scored S&P 500 stocks.
Its strongest pillar is Risk (58/100); its weakest is Business Strength (10/100).
Baxter International ranks #55 of 60 scored Healthcare stocks on Score Your Stock.
Yes. Baxter International (BAX) has a dividend yield of 0.2%, from dividends with an ex-date in the last 12 months. Its Cash & Dividends pillar scores 50/100.
From Malaysia, open an account with a broker that offers US shares (many local and app-based brokers do), convert ringgit to US dollars, then buy BAX. US shares trade one share at a time, not in lots of 100. Check the currency conversion fee and US dividend tax (usually 30% withheld for Malaysians) before you buy.
The overall score pools every measure across 5 weighted pillars: Business Strength, Financial Safety, Cash & Dividends, Price Fairness, and Risk. It uses the same rules as our Bursa scores. For banks, Financial Safety checks nonaccrual (impaired) loans, loan loss coverage and the CET1 capital ratio, from the FDIC call report of the group's main bank. Full methodology and the default weights: https://scoreyourstock.com/how. This is an educational tool, not investment advice.
Baxter International (BAX) is a Healthcare company (Medical Instruments & Supplies). On Score Your Stock's fundamentals check, it scores 35/100, rated Weak. Its biggest strength is Risk (58/100); its main watch-out is Business Strength (10/100). It also pays back about 0.2% of the share price as dividends each year. Full breakdown and daily-updated score: https://scoreyourstock.com/stocks/us/bax-baxter-international
Full Financial History
Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.
| Financial Year | Revenue | Net Profit | Operating Cash Flow | Free Cash Flow | CapEx | Cash | Total Debt | Short-Term Debt | Equity | Current Assets | Current Liabilities | Total Assets | Total Liabilities | Inventory | Dividends | Return on Equity (ROE) | Net Profit Margin | Debt-to-Equity | Current Ratio | Interest Coverage | Dividend Payout Ratio | Div yield | P/E Ratio | P/B Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | US$ 11.6b | US$ -723.0m | US$ 1.3b | US$ 812.0m | US$ -507.0m | US$ 2.1b | US$ 9.7b | US$ 844.0m | US$ 6.2b | US$ 7.0b | US$ 3.6b | US$ 19.8b | US$ 13.6b | US$ 2.3b | - | -12% | -6% | 1.6× | 2.0× | 0.3× | -25% | - | - | - |
| 2025 | US$ 11.2b | US$ -957.0m | US$ 845.0m | US$ 323.0m | US$ -522.0m | US$ 2.0b | US$ 9.8b | US$ 3.0m | US$ 6.1b | US$ 6.9b | US$ 3.0b | US$ 20.1b | US$ 14.0b | US$ 2.2b | US$ 52.0m | -16% | -9% | 1.6× | 2.3× | -0.7× | -36% | 3% | -10.5× | 1.6× |
| 2024 | US$ 10.6b | US$ -649.0m | US$ 1.0b | US$ 559.0m | US$ -460.0m | US$ 1.8b | US$ 13.4b | US$ 2.8b | US$ 7.0b | US$ 8.9b | US$ 6.5b | US$ 25.8b | US$ 18.8b | US$ 2.0b | US$ 104.0m | -9% | -6% | 1.9× | 1.4× | 0.3× | -91% | 4% | -22.8× | 2.1× |
| 2023 | US$ 10.4b | US$ 2.7b | US$ 1.7b | US$ 1.3b | US$ -436.0m | US$ 3.1b | US$ 14.1b | US$ 2.7b | US$ 8.4b | US$ 9.6b | US$ 6.5b | US$ 28.3b | US$ 19.8b | US$ 1.9b | US$ 116.0m | 32% | 26% | 1.7× | 1.5× | 1.5× | 22% | 3% | 7.0× | 2.2× |